Profil
R.
Michael Floyd was the founder of Elion Oncology, Inc., founded in 2016, and held the titles of President, Chief Executive Officer & Director at the company.
Mr. Floyd is also the founder of BioAim LLC,Exbaq LLC..
Mr. Floyd was Chief Executive Officer-North America at EvoNext Holdings SA. Mr. Floyd was Chief Operating Officer at Processa Pharmaceuticals, Inc. from 2020 to 2023.
Mr. Floyd completed undergraduate education at Georgetown University.
Ehemalige bekannte Positionen von R. Floyd
| Unternehmen | Position | Ende |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Geschäftsführer | 31.08.2023 |
BioAim LLC | Gründer | - |
Exbaq LLC | Gründer | - |
| EVONEXT HOLDINGS SA | Corporate Officer/Principal | - |
Elion Oncology, Inc.
Elion Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology related biopharmaceutical products | Gründer | - |
Ausbildung von R. Floyd
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evolva Holding SA
Evolva Holding SA Food: Specialty/CandyConsumer Non-Durables Develops and sells flavors, fragrances and health ingredients | Consumer Non-Durables |
Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Elion Oncology, Inc.
Elion Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology related biopharmaceutical products | Health Technology |
BioAim LLC | |
Exbaq LLC |
















